Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01431885 · ClinicalTrials.gov registry record · NA
Two Methods of Diagnosing Preterm Labor
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT01431885 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 82 participants.
The verdict
NCT01431885, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
Use of modern diagnostic tools e.g. fetal fibronectin and ultrasound measurement of cervical length to diagnose preterm labor can result in improved outcomes compared to traditional diagnosis based on digital examination to measure cervical change.
Interventions
- PROCEDURE Diagnosis by cervical length and fibronectin
- PROCEDURE Cervical change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01431885
The ClinicalTrials.gov registry entry for NCT01431885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diagnosis by cervical length and fibronectin is the first listed.
NCT01431885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01431885 about?
NCT01431885 is a clinical study titled "Two Methods of Diagnosing Preterm Labor". Use of modern diagnostic tools e.g. fetal fibronectin and ultrasound measurement of cervical length to diagnose preterm labor can result in improved outcomes compared to traditional diagnosis based on digital examination to measure cervical change.
What is the current status of trial NCT01431885?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2011-08. Estimated completion is 2015-02-13.
What interventions are being tested in trial NCT01431885?
The interventions under investigation include: Diagnosis by cervical length and fibronectin (PROCEDURE), Cervical change (PROCEDURE).
Who is sponsoring clinical trial NCT01431885?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.